Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-03-01
2011-03-01
Cheu, Jacob (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C436S518000
Reexamination Certificate
active
07897354
ABSTRACT:
The invention relates to novel kinase peptides and antibodies, as well as nucleic acids related to them. The peptides, antibodies and the nucleic acids are useful for the detection, staging and monitoring of the progression of a kinase-mediated disease, as well as for determining or monitoring the efficacy of treatment.
REFERENCES:
patent: 6001580 (1999-12-01), Tani et al.
patent: 6133032 (2000-10-01), Monia et al.
patent: 6258776 (2001-07-01), Hemmings et al.
patent: 6582927 (2003-06-01), Aronheim
patent: 7108992 (2006-09-01), Kastan et al.
patent: 7595154 (2009-09-01), Heinrich et al.
patent: 2004/0014095 (2004-01-01), Gerber et al.
patent: WO 01/27315 (2001-04-01), None
patent: WO 02/083933 (2002-10-01), None
patent: WO 03/087400 (2003-10-01), None
patent: WO 2004/038040 (2004-05-01), None
Campbell (Monoclonal Antibody Technology 1984, Elsevier Science Publisher; Section 1.3.4, p. 29).
Clifton, et al., “A comparison of the substrate specificity of MAKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress”; FEBS Letts.; (1996); 392: 209-214.
Leighton, et al., “Comparison of the specificiies of p. 70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p. 70 S6 kinase: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation”; FEBS Letts.; (1995); 375: 289-293.
Stokoe, et al.; “The Substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2”; Biochem. J.; (1993); 296: 843-849.
Wadsworth, et al., “RWJ 67657, a Potent, Orally Active Inhibitor of p. 38 Mitogen-Activated Protein Kinase”; J. Pharmacol & Experimental Therapeutics; (1999); 291: 680-687.
Kim et al., Biochem. Biophys. Res. Comm., vol. 310(2), pp. 542-549 (2003).
Heinrich et al., Science, vol. 299(5607), pp. 708-710 (2003).
Cheu Jacob
Evans Paula C.
Nuclea Biotechnologies, Inc.
LandOfFree
Kinase peptides and antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kinase peptides and antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase peptides and antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2711863